The article you requested is
Are Two Antidepressant Mechanisms Better Than One?
J Clin Psychiatry 1997;58:339-340
Copyright 1997 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
The classical antidepressants,
namely tricyclic antidepressants
(TCAs) and monoamine oxidase inhibitors, have multiple
pharmacologic mechanisms, but only
those increasing the availability of serotonin
(5-HT) and norepinephrine
(NE) explain antidepressant actions.
Their other actions, such as anticholinergic
properties, are responsible for
side effects.1 This profile has given
rise to the notion that multiple mechanisms
mean “dirty drugs” and that the
best drugs should be “smart bombs”
attacking only a single receptor target.